The association between risk factors for tardive dyskinesia and phenylalanine-induced abnormal movements in schizophrenia

Human Psychopharmacology

Volumn 16, Issue 3, 2001, Pages 273-277

  Schultz, S K ^a,b   Ellingrod, V ^a   Fleming, F W ^a   Andreasen, N C ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Phenylalanine; Schizophrenia; Tardive dyskinesia

Indexed keywords

AMINO ACID; CLOZAPINE; FLUPHENAZINE; HALOPERIDOL; NEUROTRANSMITTER; OLANZAPINE; PHENYLALANINE; PLACEBO; RISPERIDONE; THIORIDAZINE; TRIFLUOPERAZINE;

ADULT; AGE; ARTICLE; BRAIN; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; GENDER; HUMAN; INVOLUNTARY MOVEMENT; MOTOR DYSFUNCTION; NEUROTRANSMITTER UPTAKE; PRECURSOR; PREDICTION; PRIORITY JOURNAL; PROTEIN INTAKE; RATING SCALE; RECEPTOR SENSITIVITY; RISK FACTOR; SCHIZOPHRENIA; STATISTICAL MODEL; TARDIVE DYSKINESIA;

EID: 0035019480     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/hup.245     Document Type: Article

References (18)

1. Scale for the Assessment of Negative Symptoms (SANS)
2. Scale for the Assessment of Positive Symptoms (SAPS)
3. Plasma amino acids in relation to cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy controls
4. Affective disorders and tardive dyskinesia
5. The acute effects of a loading dose of phenylalanine in unipolar depressed patients with and without tardive dyskinesia
6. Heterogeneity of tardive dyskinesia. A multivariate analysis
7. Abnormal Involuntary Movement Scale. Assessment Manual for Psychopharmacology
8. Cross-cultural study of a biochemical abnormality in paranoid schizophrenia
9. Tardive dyskinesia exacerbated following ingestion of phenylalanine by schizophrenic patients
10. Saturation of blood brain barrier transport of amino acids in phenylketonuria
11. Phenylethylamine and schizophrenia
12. Serum phenylalanine in schizophrenia: Biochemical genetic aspects
13. The prevalence of tardive dyskinesia in a mentally retarded population
14. Tardive dyskinesia and phenylalanine metabolism: Risk factor studies
15. The plasma phenylalanine/large amino acid ratio: A risk factor for tardive dyskinesia
16. TD symptom decreases with regulation of plasma large neutral amino acids
17. Neurochemical changes following high dose aspartame with dietary carbohydrates
18. Monoamine oxidase, phenylethylamine, norepinephrine and schizophrenia